Top Saudi Food and Drug Authority Official Visits DuBiotech

Top Saudi Food and Drug Authority Official Visits DuBiotech
2.5 5

Published October 4th, 2010 - 14:49 GMT

Rate Article:

PRINT Send Mail
comment (0)
Follow >
Click here to add Bawazeir as an alert
Click here to add Dubai as an alert
Click here to add Marwan Abdulaziz as an alert
Marwan Abdulaziz
Click here to add National Reference Laboratory as an alert
Click here to add Saudi Food and Drug Authority as an alert
Click here to add TECOM Investments as an alert
TECOM Investments

Dubai-UAE: 4 October, 2010 – Dr. Saleh A. Bawazir, Vice-President of Saudi Food and Drug Authority (SFDA), visited the premises of Dubai Biotechnology and Research Park (DuBiotech), the region’s major life sciences park and a member of TECOM Investments’ newly created Sciences Cluster.

Dr. Bawazir was received by DuBiotech’s Director of Business Development, Marwan Abdulaziz.  The SFDA and Dubiotech discussed areas of cooperation and support to grow life sciences in the region and Dr. Bawazeir also toured the new state-of-the art DuBiotech laboratory complex, visiting the facilities of the National Reference Laboratory, Firmenich and Maquet based there.

The visit was organized on the sidelines  of the Clinical Trials MENA Conference, which was held in Dubai from 27 - 28 September at the Mövenpick Hotel, Dubai Marina.

Marwan Abdulaziz said: “The visit by Dr. Bawazir reiterates the importance of bilateral relations between the Saudi FDA and DuBiotech, which is helping create a strong life sciences industry in the Middle East.

“DuBiotech continues to attract international interest from both commercial and public sectors, and the 70 companies that have already chosen the free zone as their home are a testament to its vision of  becoming a global leader in the life sciences and biotechnology industries.”

Spread over 22 million square feet, DuBiotech has invested in infrastructure to offer specially tailored facilities that meet all life sciences industry requirements. The premises include the 256,000-sq ft Nucleotide Laboratory Complex compatible with the most demanding requirements, 25 warehouse facilities for manufacturing and distribution activities, and land available for new manufacturing plants and logistic platforms. In addition, the free zone offers office space in a landmark eco-friendly headquarters building as well as business centers for companies wishing to test the market before extending their commitment to the region.

Add a new comment